Motilal Oswal Securities recommends buying Gland Pharma stock. They predict a target price of Rs 1970. The brokerage expects Gland Pharma's earnings to rebound over the next few years. This growth will be driven by higher sales of existing products and new product launches. Gland Pharma's stock is currently trading at Rs 1786.4.
